EU
Europe
United Kingdom
Policy and Politics
Regulation and Legislation
Regulatory briefing
As the UK exits Europe and enters its 11-month period of transition, what does Brexit actually mean for cross-Channel relationships, and for the CBD industry in particular? ...
EU
Europe
EU regulation
Regulation and Legislation
Regulatory briefing
Epidyolex, the CBD-based medicine used to treat rare forms of epilepsy, has been approved by the European Medicines Agency (EMA) ...
North America
United States
Companies
Health
Technology and Innovation
Business briefing
Obscure cannabinoids and even completely new ones could be produced synthetically from yeast, along with THC and CBD, according to scientists at the University of California in Berkeley ...
World
Regulation and Legislation
Regulatory briefing
CBD is likely to be removed from the scope of the most significant international treaty on drug control, following a favourable report by the World Health Organization (WHO), which also recommends downgrading cannabis ...
Africa
Asia
Australasia
Canada
Europe
Mexico
New Zealand
North America
South America
United States
World
Policy and Politics
Regulation and Legislation
Regulatory briefing
Researchers in Portugal have developed an algorithm to identify characteristics that suggest the nations most likely to legalise recreational cannabis ...
North America
United States
Food
Health
Policy and Politics
Regulation and Legislation
Regulatory briefing
Removing hemp from the federal narcotics Schedule 1 list does not mean that all CBD products are now permitted, the US Food and Drug Administration (FDA) has warned ...
Austria
Europe
Regulation and Legislation
Regulatory briefing
The use of any cannabis extract in cosmetics is forbidden in Austria, authorities have recently confirmed ...
Canada
North America
United States
Companies
Health
Regulation and Legislation
Business briefing
The number of cannabidiol-based pharmaceutical products in the pipeline continues to grow, with the US Food and Drug Administration (FDA) recently granting yet another orphan drug designation for CBD ...
Europe
United Kingdom
Regulation and Legislation
Regulatory briefing
The UK’s Veterinary Medicines Directorate (VMD) has told CBD-Intel that even a product not normally considered a medicine, such as a pet food or livestock feed, will be treated as a pharmaceutical if it contains CBD ...
Canada
North America
Health
Technology and Innovation
Business briefing
Many cannabis strains marketed as distinct are in fact chemically much the same, but there may also be non-obvious differences and their effects on humans should not be judged purely on THC and CBD content, scientists say ...
Canada
North America
Regulation and Legislation
Business briefing
Canada’s cannabis age has officially dawned, with some CBD products as well as the plant itself becoming legal for retail and personal possession ...
EU
Europe
United Kingdom
Regulation and Legislation
Regulatory briefing
CBD-based medical treatments for animals will need government approval before being sold in the UK, after the country’s Veterinary Medicines Directorate (VMD) decided they fall under the definition of veterinary medicines ...
Canada
North America
United States
Companies
Technology and Innovation
Business briefing
Rare cannabinoids that cannot practically be extracted from hemp will instead be manufactured by specially-created micro-organisms in a partnership between a Canadian and a US company ...